Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Debt / NOTE 1.500%10/1
-
Market price (% of par)
-
106.01%
-
Total 13F principal
-
$308,997,716
-
Principal change
-
-$65,257,036
-
Total reported market value
-
$327,784,733
-
Number of holders
-
43
-
Value change
-
-$69,719,766
-
Number of buys
-
16
-
Number of sells
-
17
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - NOTE 1.500%10/1 as of Q1 2020
As of 31 Mar 2020,
BIOMARIN PHARMACEUTICAL INC - NOTE 1.500%10/1 was held by
43 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$308,997,716
in principal (par value) of the bond.
The largest 10 bondholders included
Invesco Ltd., Allianz Asset Management GmbH, CALAMOS ADVISORS LLC, FRANKLIN RESOURCES INC, BANK OF AMERICA CORP /DE/, ROYAL BANK OF CANADA, Polar Capital LLP, HIGHBRIDGE CAPITAL MANAGEMENT LLC, ADVENT CAPITAL MANAGEMENT /DE/, and STATE STREET CORP.
This page lists
44
institutional bondholders reporting positions
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.